Underrepresented Minority Fellowship in Gene and Cell Therapy for Oncology

ASGCT will award $100,000 to a postdoctoral or early-career oncology researcher from a racial or ethnic minority group underrepresented in the scientific workforce.  

Apply for the ASGCT Underrepresented Minority Fellowship in Gene and Cell Therapy for Oncology from June 1 to August 1.

Overview and Benefits Required Documents

Racial and ethnic minorities are underrepresented in the scientific workforce, specifically in the number of postdoctoral fellows transitioning into faculty positions. ASGCT is committed to addressing these disparities and providing opportunities for professional development in biomedical research for underrepresented groups. Therefore, the Society is initiating this $100,000 award to support one ASGCT member in a postdoctoral or early-stage investigator fellowship in gene or cell therapy-related research for an oncology indication for one year (November 2022 to December 2023).

Learn more about the eligibility requirements, application materials, and key deadlines in the Underrepresented Minority Fellowship in Oncology Overview and Benefits.

This award is supported by grants funding provided by Bristol-Myers Squibb. Learn more about opportunities to support this program.

Frequently Asked Questions

Who can apply?

Applicants must:

  1. Self-identify as Black, Indigenous, and/or Latinx.

  2. Be a member of ASGCT. Not an ASGCT member yet? Take the first step. Submit your membership application at least 5 business days prior to the application deadline to allow sufficient time for processing.

  3. Have a research focus on gene and cell therapy for oncology indications.

  4. Be a U.S. citizen or have been lawfully admitted for permanent residence.

  5. Be a postdoctoral or early-stage investigator.

  6. Have clear and documented support of an established mentor who has active noncommercial funding and will remain funded for the duration of the award term, or who is recognized through national clinical leadership (if the project is clinical). 

  7. Provide documentation from an institutional leader with the authority to ensure that at least 75 percent of the applicant's full-time professional efforts will be devoted to research during the funded period.

Show Answer
What can this grant be used for?

All funds must be used for direct expenses associated with conducting the proposed project and are non-transferable. Please refer to our Grant Policy Statement for a list of accepted costs. 

Show Answer
Is U.S. citizenship a requirement?

Applicants must either be a U.S. citizen or have been lawfully admitted for permanent residence. Mentors must be located in the United States during the duration of the research. Any visa and/or citizenship restrictions applicable to receiving the award are the responsibility of the applicant.

Show Answer
When will winners be notified?

Winners will be notified by November 15 and awards will be processed by November 30.

Show Answer


ASGCT Policy Summit

Watch On Demand Through Oct. 27

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.